Code I26: A Precise Tool to Strengthen VTE Surveillance
RPTH Journal (Research and Practice in Thrombosis and Haemostasis) shared an insightful post on LinkedIn:
”Current ICD codes make it difficult to track venous thrombosis incidence in real time. This original article suggests use of “I26″ which has high specificity for VTE in the Unite States, and may help capture the incidence of PE.
Authors: Jeffrey Kline, Jesse Wrenn, Alexis Drinkhorn, Mazin Alam, Steven Korzeniewski, Christopher Kabrhel”
Read the full article here.
Accurately tracking venous thromboembolism (VTE) incidence in real time remains a challenge with current ICD coding.
In the article ”Diagnostic accuracy of the international classification of disease ‘I26’ code to detect acute pulmonary embolism in a surveillance network” by Jeffrey Kline et al. published in RPTH Journal, the potential of using the ”I26” code is discussed.
This study highlights the potential of using the ICD code “I26”, which demonstrates high specificity for VTE in the United States, particularly for capturing pulmonary embolism cases.
Implementing this approach may improve surveillance and inform public health strategies!

For deeper insights and the latest research, be sure to read Hemostasis Today.
-
Jun 26, 2026, 07:38Baraa Nassar: High Clinical Suspicion Is Essential for Early Diagnosis of CVST
-
Jun 26, 2026, 07:10Saleh Shamse Basha: Why APTT Alone Can Be Misleading During UFH Monitoring
-
Jun 26, 2026, 06:01Nicolas Hubacz: A Sharper Look at the Brain’s Vascular Landscape
-
Jun 26, 2026, 05:57Ayse Bahar Keleşoğlu Dinçer: New Insights into Antiphospholipid Syndrome Classification and Recurrent Thrombosis Risk
-
Jun 26, 2026, 05:55Shinya Goto: How Newton’s Laws Shape Platelet Function
-
Jun 26, 2026, 05:50Andrew Emad: Five Years of Partnership, Innovation, and Impact at Africa Health ExCon 2026
-
Jun 26, 2026, 05:48Regan Bucciol: The Emerging Role of Erythrocytes in Thrombosis
-
Jun 26, 2026, 05:26Maxime Dely: Strengthening Skills in Plasma and Red Cell Exchange
-
Jun 26, 2026, 05:26Andreas Calatzis: Hidden Differences in Anti-Xa Testing